Stock Price Quote

NATCO PHARMA LTD.

NSE : NATCOPHARMBSE : 524816ISIN CODE : INE987B01026Industry : Pharmaceuticals & DrugsHouse : Natco
BSE644.003.95 (+0.62 %)
PREV CLOSE ( ) 640.05
OPEN PRICE ( ) 641.20
BID PRICE (QTY) 643.70 (31)
OFFER PRICE (QTY) 645.00 (28)
VOLUME 2516
TODAY'S LOW / HIGH ( )634.95 647.50
52 WK LOW / HIGH ( )482 707
NSE643.053.05 (+0.48 %)
PREV CLOSE( ) 640.00
OPEN PRICE ( ) 640.00
BID PRICE (QTY) 643.05 (1)
OFFER PRICE (QTY) 643.90 (1)
VOLUME 35592
TODAY'S LOW / HIGH( ) 634.75 648.00
52 WK LOW / HIGH ( )480 709.75
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-09 1981
Management Info
V C Nannapaneni - Chairman V C Nannapaneni - Managing Director
Registered Office

Address Natco House,Road No 2,Banjara Hills,
Hyderabad,
Telangana-500003

Phone 040-23547532

Email investors@natcopharma.co.in / dasaradhi@natcopharma.co.in

Website www.natcopharma.co.in

Registrars Details
Venture Capital & Corporate Investments Ltd
12-10-167,,MIG- 167,,Bharat Nagar Colony,Hyderabad
Listing : BSE, NSE, MCX

NEWS

03Jan Natco Pharma files ANDA for Tipiracil
Natco Pharma has submitted an Abbreviated New Drug Application (ANDA) co..
04Dec NITCO, Frontline Corporation and Eris
NITCO has entered into a Non-binding term sheet to appoint Hines India R..
04Dec Natco Pharma jumps on investing Rs 5 c
Natco Pharma is currently trading at Rs. 598.00, up by 15.55 points or 2..
03Dec Natco Pharma invests Rs 5 crore in OMR
Natco Pharma has completed the investment of Rs 5 crore in OMRV Hospital..
15Nov Natco Pharma starts operations at FDF
Natco Pharma has commenced commercial operations at Finished Dosage Form..

Financials

in Millions
QTR Sep 19 ANNUAL 19
Net Profit12226671
Gross Profit 1436 8474
Operating Profit 17099463
Net Sales 457719863

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  12683.55 (0.35%)
M.Cap ( in Cr)26880.37
Astrazeneca Pharma I (BSE)
peergroup  2513.00 (0.99%)
M.Cap ( in Cr)6292.00
Hester Biosciences (BSE)
peergroup  1620.00 (0.80%)
M.Cap ( in Cr)1387.13
Indoco Remedies (BSE)
peergroup  223.90 (5.74%)
M.Cap ( in Cr)2027.31
Torrent Pharma (BSE)
peergroup  2040.00 (0.58%)
M.Cap ( in Cr)34489.81

Shareholding Pattern

MUTUAL FUNDS/UTI 7.9%
PROMOTERS 48.98%
NON-INSTITUTION 19.4%
FI/BANKS/INSURANCE 1.08%
GOVERNMENT 0%
FII 0%

About Natco Pharma Ltd.

Natco Pharma Ltd. was incorporated in the year 19-09-1981. Its today's share price is 640.05. Its current market capitalisation stands at Rs 11622.6 Cr. In the latest quarter, company has reported Gross Sales of Rs. 20945 Cr and Total Income of Rs.22247 Cr. The company's management includes M Adinarayana, Sridhar Sankararaman, D Linga Rao, MUR Naidu, PSRK Prasad, Leela Digumarti, DG Prasad, Rajeev Nannapaneni, TV Rao, G S Murthy, V C Nannapaneni, V C Nannapaneni.

It is listed on the BSE with a BSE Code of 524816 , NSE with an NSE Symbol of NATCOPHARM and ISIN of INE987B01026. It's Registered office is at Natco House,Road No 2,Banjara HillsHyderabad-500003, Telangana. Their Registrars are ACC Ltd. It's auditors are Brahmayya & Co, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X